GLN368STOP MYOCILIN MUTATION IN FAMILIES WITH LATE-ONSET PRIMARY OPEN-ANGLE GLAUCOMA

PURPOSE. To examine families ascertained for late-onset primary open-a ngle glaucoma (POAG) to determine mutations in the gene coding for myo cilin. METHODS. The diagnosis of late-onset POAG was defined as age at diagnosis more than 35 years, intraocular pressure (IOP) 22 mm Hg or more in both eyes or 19 mm Hg or more while the patient was taking two glaucoma medications, glaucomatous optic neuropathy in both eyes, and visual field loss consistent with optic nerve damage in at least one eye of the proband. Two of three criteria were required in other famil y members. DNA from all families was screened for polymorphisms in myo cilin using single-strand conformation polymorphism analysis. All poly morphisms were sequenced for mutations. RESULTS. Eighty-three affected people in 29 families with late-onset POAG were screened for mutation s. Three mutations, two novel missense (Thr377Met and Glu352Lys) and o ne nonsense (Gln368STOP), were identified. The missense mutations did not segregate with the disease phenotype in these families. The nonsen se mutation was found in 3 of 29 unrelated families with POAG. All aff ected family members and 8 of 12 in whom glaucoma was suspected had th e Gln368STOP mutation. All people with this mutation had elevated IOP, and 78% had POAG by age 70. CONCLUSIONS. Three mutations were identif ied in the gene coding for myocilin in families with late-onset POAG;. Of these, the Gln368STOP mutation was highly associated with the deve lopment of glaucoma. Ail people with this mutation had glaucoma or ele vated IOP by age 70. in the United States, the Gln368STOP mutation in myocilin is strongly associated with the development of late-onset POA G. However, factors in addition to the presence of this mutation seem to play a role in the development of ocular hypertension and glaucoma in these families.